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ABSTRACT 
 
Background 
A 13 years old female child presented with complains of breathing difficulty with concurrent swelling of whole face and neck 
region. This presentation was preceded by mild trauma over lips only one day back. The injury was quite innocuous in nature. 
There was history of similar episodes in family. Family pedigree chart shows similar episodes in grandfather, uncle and two 
sisters of her father. She is only one affected out of four sisters in her family. Her father died with same problem 12 years back.  
Her C1-INH was assessed quantitatively and functionally. Her C1 esterase inhibitor (C1-INH) level is normal in quantification 
assay but significantly below normal functionally. The case was diagnosed as a case of Hereditary angioedema disguising as 
recurrent allergic manifestations leading to anaphylactic reaction like feature. This condition does not respond to classical 
antihistaminics or steroids. This presentation further highlights significance of consideration of above mentioned condition in 
patient reporting for repeated allergic and anaphylactic reactions. 
Keywords: hereditary angioedema, laryngeal edema, minor trauma, anaphylaxis. 
Introduction 
Hereditary angioedema (HAE) is an autosomal 
dominant disease caused by low functional levels of 
the plasma protein C1-INH[1,2].Patients typically 
report episodic attacks of angioedema or deep localized 
swelling, most commonly on a hand or foot, which 
begins during childhood and becomes much more 
severe during adolescene[3]. Cutaneous non-pitting 
and non-pruritic edema is associated with urticaria 
presents as commonest symptom. The swelling 
becomes more severe over about 1.5 days and those 
resolves over about same period. 
 In some patients attack are preceded by the 
development of rash, which is erythema marginatum & 
is associated with erythematous lesion which not raised 
non pruritic. 
The second major symptom complex noted by patients 
is attack of severe abdominal pain caused by edema of 
the mucosa of any portion of gastro-intestinal tract. It 
may lead to life threatening complication of laryngeal 
edema [4]. 
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There is depression of complements C4 and C2 during 
an attack significantly reducing the CH5c. Typically, C4 
is low and C3 normal or slightly decreased [5,6] 
HAE is classified into three types of dysfunction:  
1. Type 1 HAE is caused by decreased production or 
absence of C1 esterase inhibitor (C1-INH)[5,6]  
2. Type 2 HAE is characterized by normal C1-INH 
level indicating functional impairment [7]. 
3. Type 3 HAE has been described in female only and 
presents normal function C1-INH levels [8]. 
 
Case description 
 
13 years old female child was brought to hospital with 
complain of breathing difficulty and swelling of whole 
face and neck followed by mild trauma over lips. Past 
history includes similar episodes (6-7 times) occurred 
in past. Last episode occurred about 4 months ago. 
History of minor trauma such as trauma while brushing 
her teeth, playing etc was always presents preceding an 
attack of angioedema. Earlier she used to take Tab Avil 
and Dexona for relief but this was first time she was 
hospitalized.  
Family history of similar episodes in her grandfather 
then her father, one uncle and two of her father's sister 
is present. She is only one affected among her siblings. 
 
Asian Pac. J. Health Sci., 2018; 5(3):178-181                                            e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________  
Verma et al                   ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2018; 5(3):178-181 
www.apjhs.com                                    179 
 
12 years back her father died with same problem. He 
was never hospitalized nor investigated. 
After admission she was advised Inj Avil, 
Hydrocortisone, Nebulisation with levolin, moist o2 
inhalation, monitoring of vitals. Within 12 hours she 
recovered. She was investigated for CBC,RFT,LFT, 
serum electrolyte, IgE  levels, absolute eosinophil 
count, serum tryptase level, serum C1-INH level and 
function. In these CBC, RFT, LFT, serum electrolyte 
were normal. 
 Her C1 Esterase Inhibitor - Quantification (C1 
Inactivator – Quantitative)(Radial Immuno 
diffusion)  was 95 mg/L (normal) 
Her C1 Esterase Inhibitor - Functional (C1 
Inactivator - Functional) was 4 % (below 40 % is 
considered abnormal),  thus confirming the diagnosis. 
 
 
 
Fig 1: A 13-year-old girl exhibiting diffuse facial swelling involving forehead and both the eyes 
 
 
Fig 2: Recovery of the 13-year-old girl after 5 days 
 
Discussion 
 
There are many known HAE episode inciting factors, 
including physical injury, medical or dental operations, 
psychological stress, menstruation, infections or certain 
medications – a list that includes contraceptive pills 
and angiotensin-converting enzyme (ACE) inhibitors. 
During the acute phase of an HAE episode 
manifestations may include diffused skin, peptic and 
respiratory mucosa oedema. Cerebral oedema may also 
occur, leading to migraine type pain, as well as 
cerebrovascular  incidents . Face oedema may be 
limited to the eyelids only or may extended to its entire 
surface, the lips and, rarely, to the oral cavity (tongue 
and soft palate)
7
. The combination of lip swelling in the 
form of cheilitis glandularis and face swelling, which 
constitute the characteristic clinical findings of 
Melkersson–Rosenthal syndrome can, during the first 
stages of its appearance, lead to the mistaken diagnosis 
of angioedema. A tip for helping differentiate the two 
is that in the case of cheilitis glandularis lip swelling is 
stable and it is not accompanied by other findings that 
lead to the diagnosis of angioedema. 
Gastrointestinal system symptoms are caused by 
visceral oedema, which include anorexia, nausea/or 
vomiting and abdominal pain. Fluid extravasations into 
the peritoneal cavity as a result of vasodilatation in 
HAE may sometimes lead to ascites and fluid 
imbalance that can lead to hemodynamic shock, which 
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requires aggressive fluid resuscitation to prevent this 
potentially severe complication[3] 
A common presentation of an HAE episode 
concentrated in the gastrointestinal tract is severe 
abdominal pain accompanied by nausea or vomiting 
and is often indistinguishable from an acute abdomen. 
This can lead to misdiagnosis and unnecessary surgical 
operations, of which appendectomy is the most 
common. Gastrointestinal tract attacks usually subside 
within 12 - 24 hours[3] 
Findings similar to those seen in HAE can be observed 
in patients prescribed ACE inhibitors for hypertension 
or/and congestive heart failure treatment. The 
incidence of angioedema in patients taking ACE 
inhibitors is approximately 0.1% to 0.5%. 
Distinguishing between HAE and angioedema induced 
by ACE inhibitors is achieved by reviewing the 
patient's medical history and their C1-INH levels: 
Those with ACE-induced angioedema will relate no 
prior episodes of angioedema, will note that their 
angioedema did not develop until they were treated 
with  ACE, C1-INH levels will be normal in this 
situation. 
For patients who develop ACE-induced angioedema 
the issue should resolve with discontinuation of the 
ACE. The physician then provides the patient an 
alternative therapy instead of an ACE for the condition 
being treated
7
. 
HAE usually presents during the second decade of life 
but may also appear at other ages. Bork et al, having 
studied 123 cases of HAE patients, came to the 
conclusion that first HAE appearance was most 
frequently seen between 11 to 45 years of age, while 
the youngest known confirmed case at that time was 3 
years old.  
The intervals between HAE crises differ between 
patients and may also differ in the same patient. 
Factors that influence frequency of HAE episodes 
among others depend on motivating factors existence 
and whether the patient is being prescribed long-term 
medication prophylaxis. 
As stated previously, oedema can affect many body 
regions but laryngeal oedema constitutes the most 
worrisome potential symptom of HAE, as it can cause 
death by asphyxiation. Life-threatening laryngeal 
oedema can be an HAE patient's initial presenting HAE 
symptom, it might follow face or extremity oedema, or 
it could appear during every episode in a specific HAE 
patient.  
 Bork and Barnstedt report four fatal laryngeal oedema 
cases in HAE patients where oedema appeared 4 to 30 
hours following tooth extraction. The patients' medical 
history examination revealed that 3 out of these 4 
patients had developed laryngeal oedema for the first 
time. C1-INH was not administered to any of them 
either prophylactically or therapeutically a factor that 
may have contributed to their poor clinical outcomes.  
Bork et al., after studying 123 HAE patients, concluded 
that roughly half of them (61 patients – 49, 6%) had 
experienced one or more laryngeal oedema episodes. 
When they compared the incidences of laryngeal 
oedema to skin oedema to oedema of internal organs, 
the oedema rate was found to be laryngeal : skin : 
internal organs = 1 : 70 : 54. They thus concluded that 
upper airway system attack (larynx) is less common (1 
laryngeal oedema in 125 angioedema episodes). They 
further noted that the interval between the initial 
appearance of laryngeal oedema and its complete 
appearance ranged from 8 to 12 hours, with the mean 
time being 8.3 hours (only one patient had laryngeal 
oedema that appeared in less than 3 hours) . 
According to the above researchers, factors that 
increase likelihood of laryngeal oedema in HAE are: 
• Preceding dental operation or general anaesthesia 
(intubation); 
• Age between 11 - 45 years; 
• Prior, or multiple, laryngeal oedema episodes; 
• Prior episode of face oedema (face oedema does not 
always precede laryngeal oedema). 
They also described the following factors that reduce 
the likelihood of laryngeal oedema in HAE: 
• Age under 11 years and over 45 years; 
• Absence of prior laryngeal oedema episode (one must 
still keep in mind that even first episode of laryngeal 
involvement could be fatal episode; 
• Long-term medical prophylactic therapy. 
The management of HAE is multifactorial and consists 
of long-term maintenance/prophylaxis a factor that 
includes avoidance of situations or activities known to 
incite episodes in the specific patient, prophylaxis prior 
to dental or medical procedures(short-term 
prophylaxis) and, finally, medical management of 
acute angioedema episodes (acute phase) . If one 
excludes C1-INH, angioedema prevention measures 
include attenuated androgen administration (danazol-
stanozolol), fresh frozen plasma (FFP), and 
antifibrogenolytic factors such as E-aminocaproic acid 
and tranexamic acid. Corticosteroids and 
antihistamines administration is not helpful in HAE 
patients. C1-INH provided before medical and dental 
procedures is effective in the prevention of angioedema 
as well as in the management of acute HAE episodes, 
including laryngeal oedema. Alternatively, 
preoperative administration of FFP is recommended, 
especially in those countries where C1-INH is not 
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available. However, FFP administration has two 
disadvantages:  
1. Possible transmission of contagious disease, 
including hepatitis B, C and HIV infection, amongst 
others, because it is a biological product   
2. Aanaphylactic shock or resurgence of angioedema 
due to the fact that FFP consists of supplement factors, 
including C4.  
 
Accordingly, FFP administration is not recommended 
in acute angioedema episodes because C4 excess 
caused by FFP can intensify existing oedema. For these 
reasons Turner et al. suggest administration of 
recombinant plasma kallikrein inhibitor (OX-88) use 
prior to dental operation in the hopes of preventing 
bradykinin formation, a factor responsible for 
angioedema appearance. 
Conversely, some authors underline the necessity of 
further clinical studies for evaluating the safety and 
effectiveness of this factor in both the prophylaxis and 
acute management of HAE patients. 
Factors that combat fibrinogenolysis, including E-
aminocaprioc acid and tranexamic acid, are used in 
long-term HAE prophylaxis. These factors impede C1 
and plasmin activation. Attenuated androgens 
(danazol-stanozolol) are the most frequently used 
prophylactic regimen in the management of HAE. 
Androgens are clinically proven to reduce oedema 
occurrence in skin and internal organs as well as 
abdominal pain. They also reduce both the frequency 
and severity of laryngeal oedema episodes. 
Nevertheless, their use is limited due to their numerous 
and significant side effects, including weight gain, 
headache, myalgia, hypertension, libido decrease and 
liver concerns, including hepatic adenomas and hepatic 
carcinoma. Additionally, side effect concerns specific 
to female include menstrual disturbances and 
masculinization (muscle hypertrophy, breast reduction, 
and deepening of voice). The presence of these 
possible side effects has resulted in the need for 
minimal dosing in these populations and the 
recommendation that children and young women be 
excluded from using attenuated androgens as a 
prophylactic regimen in their HAE management 
strategy. 
Administration of C1-INH factor is effective in both 
dental and medical procedural prophylaxis and 
treatment of acute HAE episodes, including laryngeal 
oedema. Studies have revealed that failure to 
administrate C1-INH on laryngeal oedema was fatal to 
patients. Also, because HAE is not an allergic 
condition, corticosteroid and antihistamines 
administration does not constitute an effective therapy. 
Awareness among doctors, paramedicals, and general 
public is essential as it is not an allergic condition and 
doesnot responds to usual antihistaminics and 
corticosteroids. 
Screening of condition among relatives of confirmed 
cases is essential. 
Finally, the importance of educating patients and their 
relatives about the disease and its potentially severe 
complications, including acute laryngeal oedema, 
cannot be stressed highly enough. Patients must truly 
understand that the best way to prevent possibly 
avoidable loss of life from laryngeal oedema is early 
recognition followed by presentation of the patient for 
emergency care. 
 
Conclusion 
 
Prevention and early recognition of potential laryngeal 
oedema that can occur as a complication of minor 
trauma may be lifesaving for HAE patients. 
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